JAN 26, 2016 10:28 AM PST

Assess Your Alzheimer's Risks Online in 10 Minutes

WRITTEN BY: Xuan Pham
Alzheimer’s disease affects a staggering 44 million people worldwide. This number might actually be even greater, as some people with the condition go undiagnosed. But what if you could take a simple questionnaire to assess your risk of developing dementia? If a 10-minute test could reveal your likelihood for dementia, wouldn’t you like to find out?
 
Memory survey calculates your risk for Alzheimer's

The Dementia Risk Assessment, available at Alzcast.org, is a free online self-assessment tool that evaluates your risk of developing dementia. The assessment itself contains a short memory survey with simple word pairs, followed by a brief questionnaire about your health, lifestyle, and medical history. The assessment can also be taken for a friend or relative for whom you have concerns. Importantly, all answers and reports are completely anonymous.
 
“If we can identify people who have Alzheimer’s brewing before they have symptoms, we can treat the disease sooner,” says Jason Brandt, director of the Division of Medical Psychology at Johns Hopkins University School of Medicine, and creator of the assessment. “If we could delay the onset of symptoms by five years, we could reduce the number of people with Alzheimer’s by half.”
 
After completing the assessment, you will receive immediate feedback on you performance and risks for dementia. This includes a comparison of how well you scored on the memory survey relative to other people of the same sex and age. Based on this and answers to the health and lifestyle questions, the report also calculates your likelihood of developing dementia. And finally, the report also adds some personalized suggestions for you on maintaining overall brain health.
 
Will this test give the definitive diagnosis for Alzheimer’s risk? Absolutely not. Nor was it designed to do so. Far from replacing clinical exams and actual patient-doctor contact, the tool is intended to support and facilitate the tough conversations about mental health. With the self-assessed reports in hand, high-risk patients can follow up with their clinicians and determine the appropriate next steps for therapy, and possibly prevention.
 
Alzheimer’s disease is the most common cause of dementia in the elderly, and is the sixth leading cause of death in the United States. While there are no cures as of yet, early detection and diagnosis of this disease can significantly influence treatments and how the disease progresses for some patients. Thus, knowing can make a huge difference. 
 

Additional source: Johns Hopkins Medicine press release 
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUL 19, 2019
Clinical & Molecular DX
JUL 19, 2019
Possible Non-Hormonal Treatment For Endometriosis On Horizon
With over 200,000 cases reported annually, endometriosis is a big concern in women’s health. Scientists don’t yet know what causes the painful ...
SEP 17, 2019
Clinical & Molecular DX
SEP 17, 2019
An All-Inclusive Genetic Testing Made Easy for the Prospective Parents
An increasing number of parents are opting their babies in for at-home genetic testing. These at-home ...
SEP 22, 2019
Technology
SEP 22, 2019
Blood Incubation Using Laser Technology
The world’s first ever blood incubator was developed using laser technology and could someday prevent fatal blood transfusions in critically ill pati...
OCT 14, 2019
Genetics & Genomics
OCT 14, 2019
Researchers Develop a Score to Quantify the Risk of Epilepsy
It usually takes two seizures before a person can be diagnosed with epilepsy. New work can help change that....
NOV 26, 2019
Immunology
NOV 26, 2019
The Immune System's Hand in Toxic Shock
While rare, toxic shock is a dangerous condition that acts fast and can be fatal. A new study identified a new target for treating toxic shock, a component...
FEB 15, 2020
Clinical & Molecular DX
FEB 15, 2020
FDA nod for AI-powered technology to detect strokes
The US Food and Drug Administration (FDA) has provided clearance for a novel technology that uses artificial intelligence (AI) to detect strokes. The platf...
Loading Comments...